id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1146,18186149,2008,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{cyc:N-C}{ct:Amid},6k-f17,Amidation,Free,Cyclic,D,None,17,Antimicrobial,MHC = 325 µM,Human,Synthetic peptide,random coil,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
1150,18186149,2008,kkkkkkaafaawaafll,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}L{d}L{d}{cyc:N-C}{ct:Amid},"6k-f17-2l16,17",Amidation,Free,Cyclic,D,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CCSGGGTTTTTHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
1246,18779649,2008,gwgsffkkaahvgkhvgkaalthyl,G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid},D-Pleurocidin,Amidation,Free,Linear,D,None,25,Antibacterial,19% Hemolysis at 100 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1247,18779649,2008,gwgsffkkaahvgkhvgkaalthyl,G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid},D-Pleurocidin,Amidation,Free,Linear,D,None,25,Antibacterial,0% Hemolysis at 3.13-50 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1975,11478963,2001,lklksivswakkvl,L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid},D-MP-B,Amidation,Free,Linear,D,None,14,Hypotensive,82-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1976,11478963,2001,lklksivswakkvl,L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid},D-MP-B,Amidation,Free,Linear,D,None,14,Hypotensive,83-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
2005,21928440,2011,cgetcvggtcntpgctcswpvctrnglnpv,C{d}G{d}E{d}T{d}C{d}V{d}G{d}G{d}T{d}C{d}N{d}T{d}P{d}G{d}C{d}T{d}C{d}S{d}W{d}P{d}V{d}C{d}T{d}R{d}N{d}G{d}L{d}N{d}P{d}V{d}{cyc:N-C},D-Kalata B1,Free,Free,Cyclic,D,None,29,Anticancer and Anti-HIV,IC50 = 77 µM,Human,Kalata analog (Oldenlandia affinis),NA,NA,CCCSSSSCCCCCTTTTCCCCSSSSSCSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
2250,12384369,2002,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid},All-D F17-6K,Amidation,Free,Linear,D,None,17,Antimicrobial,2% Hemolysis at 200 µM,Rabbit,Synthetic peptide,NA,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
2251,12384369,2002,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid},All-D F17-6K,Amidation,Free,Linear,D,None,17,Antimicrobial,0% Hemolysis at 50 µM,Rabbit,Synthetic peptide,NA,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
2252,12384369,2002,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid},All-D F17-6K,Amidation,Free,Linear,D,None,17,Antimicrobial,0% Hemolysis at 200 µM,Human,Synthetic peptide,NA,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
2253,12384369,2002,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid},All-D F17-6K,Amidation,Free,Linear,D,None,17,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic peptide,NA,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
2437,10795591,2000,rggrlcycrrrfcvcvgr,R{d}G{d}G{d}R{d}L{d}C{d}Y{d}C{d}R{d}R{d}R{d}F{d}C{d}V{d}C{d}V{d}G{d}R{d}{ct:Amid},dPG-1,Amidation,Free,Linear,D,None,18,Antimicrobial,90% Hemolysis at 80 μg/ml,Human,PG-1 analog,NA,NA,CCSCCSCCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
2534,10821683,2000,cklllkwllkllkc,C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C},"cyclic-[D]-L3,4,8,10-K4L7W",Free,Free,Cyclic,D,None,14,Cytolytic,90% hemolytic at 50 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
2535,10821683,2000,CH3-S-cklllkwllkllkc-S-CH3,C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{nt:CH3-S-}{ct:-S-CH3},"linear-[D]-L3,4,8,10-K4L7W",Free,Free,Linear,D,None,14,Cytolytic,5% hemolytic at 50 µM,Human,Synthetic peptide,NA,NA,NA,NA
2624,22869378,2013,kklallalkkwllalkklallalkk,K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}L{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid},D-LAK120,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 4.06±1.30 µM,Human,Synthetic peptide,NA,NA,CCCHHHHHHHHHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2625,22869378,2013,kklallalkkwlpalkklallalkk,K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid},D-LAK120-P13,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 11.66±0.03 µM,Human,Synthetic peptide,NA,NA,CCSHHHHHHHHHHHHHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2626,22869378,2013,kklalalakkwlalakklalalakk,K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}A{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid},D-LAK120-A,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 17.42±2.17 µM,Human,Synthetic peptide,NA,NA,CHHHHHHHHHHHHHHHHHHHTGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2627,22869378,2013,kklalalakkwlplakklalalakk,K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}P{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid},D-LAK120-AP13,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 58.61±10.41 µMc,Human,Synthetic peptide,NA,NA,CHHHHHTGGGGHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2628,22869378,2013,kklalhalkkwlhalkklahlalkk,K{d}K{d}L{d}A{d}L{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}H{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid},D-LAK120-H,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 20.29±2.42 µM,Human,Synthetic peptide,NA,NA,CCSSSSHHHHCSHHHHCCGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2629,22869378,2013,kkalahalkkwlpalkklahalakk,K{d}K{d}A{d}L{d}A{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid},D-LAK120-HP13,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 79.61±2.80 µM,Human,Synthetic peptide,NA,NA,CGGGSSSGGGHHHHHHHCSGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2630,22869378,2013,kkalakalkhwlpalhklakalakk,K{d}K{d}A{d}L{d}A{d}K{d}A{d}L{d}K{d}H{d}W{d}L{d}P{d}A{d}L{d}H{d}K{d}L{d}A{d}K{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid},D-LAK80-HP13,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 8.61±0.35 µM,Human,Synthetic peptide,NA,NA,CHHHHHHHSSTTTCSCHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2631,22869378,2013,kkalkhalakwlpalkalahklakk,K{d}K{d}A{d}L{d}K{d}H{d}A{d}L{d}A{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}A{d}L{d}A{d}H{d}K{d}L{d}A{d}K{d}K{d}{ct:Amid},D-LAK160-HP13,Amidation,Free,Linear,D,None,25,"Antimicrobial, Antiplasmodial and Anticancer",HC50 = 185.0±18.65 µM,Human,Synthetic peptide,NA,NA,CTTTSCGGGTHHHHHHHSSSTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2800,20858205,2011,kwksflktfksakktvlhtalkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D1,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 421.5 μg/ml,Human,Synthetic peptides,NA,NA,CCHHHHHHHHHCGGGGCSHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2801,20858205,2011,kwksflktfksakktvlhtllkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D2,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 83 μg/ml,Human,Synthetic peptides,NA,NA,CCHHHHHHTTSSTTTTCSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2802,20858205,2011,kwksflktfkslkktvlhtllkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D3,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 14 μg/ml,Human,Synthetic peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2803,20858205,2011,kwksflktfkslkktvlhtllkliss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D4,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 3.5 μg/ml,Human,Synthetic peptides,NA,NA,CCHHHHHHHHHHHHHHSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2804,20858205,2011,kwksflktfkslkktklhtllkliss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}K{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D5,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 47 μg/ml,Human,Synthetic peptides,NA,NA,CCHHHHHHHHHHTTSSSSSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2806,20858205,2011,llgdefrkskekigkefkrivqrikdflrnlvprtes,L{d}L{d}G{d}D{d}E{d}F{d}R{d}K{d}S{d}K{d}E{d}K{d}I{d}G{d}K{d}E{d}F{d}K{d}R{d}I{d}V{d}Q{d}R{d}I{d}K{d}D{d}F{d}L{d}R{d}N{d}L{d}V{d}P{d}R{d}T{d}E{d}S{d},D-LL37,Free,Free,Linear,D,None,37,Antimicrobial,HC50 = 125 μg/ml,Human,Synthetic peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
2819,21219588,2011,kwksflktfksavktvlhtalkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D1 (V13),Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 1.8 µM,Human,Synthetic peptides,NA,NA,CCTTTTTHHHHHHHHHCSHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2820,21219588,2011,kwksflktfksakktvlhtalkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},D1 (K13),Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 140.9 µM,Human,Synthetic peptides,NA,NA,CCHHHHHHHHHCGGGGCSHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2821,21219588,2011,kwksflktfskakkkvlktalkaisk,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}V{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid},D11,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 254.1 µM,Human,Synthetic peptides,NA,NA,CCTTTHHHHHHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2822,21219588,2011,kwksflktfskakkkalktllkaisk,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid},D22,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 81.3 µM,Human,Synthetic peptides,NA,NA,CCHHHHHHHHHHHHHHHHHHGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2823,21219588,2011,kwksflktfskakkkklktllkaisk,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid},D14,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 351.5 µM,Human,Synthetic peptides,NA,NA,CCHHHHHHTHHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2824,21219588,2011,klksllktlskakkkllktalkalsk,K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}L{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D15,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 169.6 µM,Human,Synthetic peptides,NA,NA,CHHHHHHHHHHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2825,21219588,2011,klksllktlskakkkklktllkalsk,K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D16,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,HC50 = 1342.0 µM,Human,Synthetic peptides,NA,NA,CGGGHHHHHHHHHHHHGGGTGGGTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2878,21335383,2011,kklfkkilkyl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP153,Amidation,Free,Linear,D,None,11,Antimicrobial,50±2.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2907,21343499,2011,kwklfkkipkflhlakkf,K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},HDP D-P18,Amidation,Free,Linear,D,None,18,Antimcrobial and Hemolytic,~94% hemolytic at 500 µM,Human,Host defense peptides analog (Rana temporaria),NA,NA,CCCSCSCCTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2908,21343499,2011,kwklfkkipkflhlakkf,K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},HDP D-P18,Amidation,Free,Linear,D,None,18,Antimcrobial and Hemolytic,~10% hemolytic at 50 µM,Human,Host defense peptides analog (Rana temporaria),NA,NA,CCCSCSCCTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
3307,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,0% Hemolysis upto 80 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3308,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,1% Hemolysis at 100 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3309,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,2% Hemolysis at 200 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3574,18984589,2009,akklohalhoallalohlahollakk,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid},D-HALO-rev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antimicrobial and Antiplasmodial,HC50 = 716.8 µM,Human,Synthetic peptide,NA,NA,NA,NA
3575,18984589,2009,akklohalhoallalohlpholkkff,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid},D-HALO-P8Frev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antimicrobial and Antiplasmodial,HC50 >65.2 µM,Human,Synthetic peptide,NA,NA,NA,NA
3798,9204560,1997,frlkfh,F{d}R{d}L{d}K{d}F{d}H{d},66-10,Free,Free,Linear,D,None,6,Antimicrobial,0% Hemolysis at 312 to 0 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
3799,9204560,1997,frlkfh,F{d}R{d}L{d}K{d}F{d}H{d},66-10,Free,Free,Linear,D,None,6,Antimicrobial,0% Hemolysis at 312 to 0 μg/ml,Bovine,Synthetic Peptide,NA,Non-hemolytic,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
3800,9204560,1997,frlkfh,F{d}R{d}L{d}K{d}F{d}H{d},66-10,Free,Free,Linear,D,None,6,Antimicrobial,0% Hemolysis at 312 to 0 μg/ml,Ovine,Synthetic Peptide,NA,Non-hemolytic,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
3975,18568863,2008,kwksflktfksavktvlhtalkaiss,K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid},DV681,Amidation,Acetylation,Linear,D,None,26,Antimicrobial,MHC = 7.8 μg/ml,Human,Synthetic Peptide,NA,NA,CCTTTTTHHHHHHHHHCSHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
4125,18984589,2009,akklohalhoallalohlahollakk,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid},D-HALO-rev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antiparasitic,HC50 = 716.8 µM,Human,Synthetic Peptide,NA,NA,NA,NA
4126,18984589,2009,akklohalhoallalohlpholkkff,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid},D-HALO-P8F-rev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antiparasitic,HC50 >65.2 µM,Human,Synthetic Peptide,NA,NA,NA,NA
4410,23925670,2013,fwgalakgalklipslfssfskkd,F{d}W{d}G{d}A{d}L{d}A{d}K{d}G{d}A{d}L{d}K{d}L{d}I{d}P{d}S{d}L{d}F{d}S{d}S{d}F{d}S{d}K{d}K{d}D{d},D-Pin2,Free,Free,Linear,D,lowercase letters correspond to D-amino acids,24,Antimicrobial,50 % Hemolysis at 10 µM,Human,African Scorpion Pandinus Imperator,α-Helical,NA,CCTTSSSSGGGTHHHHHHHHCCCC,NA
4494,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 1.3 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4495,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 2.5 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4496,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 5 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4497,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 10 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4498,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 20 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4499,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 40 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4500,24041699,2013,llcialrkk,L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},D-CopA3,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,9,Antifungal,0 % Hemolysis at 80 µM,Human,Truncated Coprisin Analog Peptide,α-Helical,Non-hemolytic,CCTTTSCCC,NA
4754,24211081,2014,irikirik,I{d}R{d}I{d}K{d}I{d}R{d}I{d}K{d}{ct:Amid},IK8-all D,Amidation,Free,Linear,D,None,8,Antimicrobial,10 % Hemolysis at 1750 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
4755,24211081,2014,irikir,I{d}R{d}I{d}K{d}I{d}R{d}{ct:Amid},IK6-all D,Amidation,Free,Linear,D,None,6,Antimicrobial,10 % Hemolysis at >2000 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
4756,24211081,2014,irik,I{d}R{d}I{d}K{d}{ct:Amid},IK4-all D,Amidation,Free,Linear,D,None,4,Antimicrobial,10 % Hemolysis at >2000 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4757,24211081,2014,IrIkIrIk,IR{d}IK{d}IR{d}IK{d}{ct:Amid},IK8-4D,Amidation,Free,Linear,D,None,8,Antimicrobial,10 % Hemolysis at >2000 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
4760,24211081,2014,irvkirvkirvk,I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}{ct:Amid},IK12-all D,Amidation,Free,Linear,D,None,12,Antimicrobial,10 % Hemolysis at >125 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCCSSSSCCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
4762,24211081,2014,iirkiirk,I{d}I{d}R{d}K{d}I{d}I{d}R{d}K{d}{ct:Amid},Control-all D,Amidation,Free,Linear,D,None,8,Antimicrobial,10 % Hemolysis at >2000 mg/L,Rabbit,Synthetic,β-Sheet,NA,CGGGTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
5189,24670666,2014,ffhhifrgivhvgktihrlvtg,F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid},D-Piscidin 1,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,22,Antimicrobial,50 % Hemolysis at 1.8 µM,Human,Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female),α-Helix,NA,CCCHHHHSSTTTCCSCCC,NA
5190,24670666,2014,ffhhifrgivhvkktihrlvtg,F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}K{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid},D-Piscidin 1 G13K,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,22,Antimicrobial,50 % Hemolysis at 7 µM,Human,Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female),α-Helix,NA,CCSTGGGSSTTTCCCSCC,NA
5191,24670666,2014,ffhhifrgivhkgktihrlvtg,F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}K{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid},D-Piscidin 1 V12K,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,22,Antimicrobial,50 % Hemolysis at 35 µM,Human,Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female),α-Helix,NA,CCSCGGGSCSCSCCTTCC,NA
5192,24670666,2014,ffhhifrgkvhvgktihrlvtg,F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}K{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid},D-Piscidin 1 I9K,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,22,Antimicrobial,50 % Hemolysis at 98 µM,Human,Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female),α-Helix,NA,CCCCCCCCCTTSSSSSCC,NA
5193,24670666,2014,alwmtllkkvlkaaaakalnavlvgana,A{d}L{d}W{d}M{d}T{d}L{d}L{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid},D-Dermaseptin S4,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,27,Antimicrobial,50 % Hemolysis at 0.6 µM,Human,South American Frogs Of The Phyllomedusa,α-Helix,NA,CHHHHHHHHHHHHHHHHHHTTSCCCCCC,NA
5194,24670666,2014,alwmtlkkkvlkaaaakalnavlvgana,A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid},D-Dermaseptin S4 L7K,Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,27,Antimicrobial,50 % Hemolysis at 8.6 µM,Human,Derivative Of D-Dermaseptin S4,α-Helix,NA,CCCHHHHHHHHHHHHHHHHTTCCCCCCC,NA
5195,24670666,2014,alwmtlkkkvlkakakalnavlvgana,A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}K{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid},"D-Dermaseptin S4 L7K,A14K",Amidation,Amidation,Linear,D,lowercase letters correspond to D-amino acids,27,Antimicrobial,50 % Hemolysis at 241 µM,Human,Derivative Of D-Dermaseptin S4,α-Helix,NA,CCCHHHHHHHHHHHHHTTSSSCSSCCC,NA
5385,25807936,2015,k6#k,K{d}{nnr:6#}K{d}{ct:Amid},P3,Amidation,Free,Linear,D,"6# = BDZ,benzodiazepine scaffold",2,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5390,25807936,2015,k6#fk,K{d}{nnr:6#}F{d}K{d}{ct:Amid},P8,Amidation,Free,Linear,D,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
6031,26574005,2016,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid},BP214,Amidation,Free,Linear,D,None,18,Antimicrobial,42 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6157,26998557,2016,gimsslmkklkkiiak,G{d}I{d}M{d}S{d}S{d}L{d}M{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-9,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6161,26998557,2016,gilssllkklkkiiak,G{d}I{d}L{d}S{d}S{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-13,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 373 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6169,26998557,2016,gilsslwkklkkiiak,G{d}I{d}L{d}S{d}S{d}L{d}W{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-21,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6190,26795535,2016,rglrrlgrkiahgvkkygptvlriiria,R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid},SMAP-29-E1,Amidation,Free,Linear,D,i = D-Isoleucine,28,"Antimicrobial, Anti-MRSA",10 % Hemolysis at 5.5 µM,Human,Smap-29 D-Enantiomeric Peptides,α-Helix,NA,CCHHHHHHHHCSSTTSHHHHHHCCCCC,NA
6191,26795535,2016,rglrrlgrkiahgvkkygptvlriiria,R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid},SMAP-29-E2,Amidation,Free,Linear,D,i = d-allo-isoleucine,28,"Antimicrobial, Anti-MRSA",10 % Hemolysis at 16 µM,Human,Smap-29 D-Enantiomeric Peptides,α-Helix,NA,NA,NA
6195,26795535,2016,rglrrlgrkiahgvkkyg,R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid},SMAP-18-E1,Amidation,Free,Linear,D,i = D-Isoleucine,18,"Antimicrobial, Anti-MRSA",10 % Hemolysis at <512 µM,Human,Smap-18 D-Enantiomeric Peptides,α-Helix,NA,CCHHHHGGGTSSTTTCC,NA
6196,26795535,2016,rglrrlgrkiahgvkkyg,R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}{nnr:i}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid},SMAP-18-E2,Amidation,Free,Linear,D,i = d-allo-isoleucine,18,"Antimicrobial, Anti-MRSA",10 % Hemolysis at <512 µM,Human,Smap-18 D-Enantiomeric Peptides,α-Helix,NA,NA,NA
6812,27900727,2016,idwkklldaakqil,I{d}D{d}W{d}K{d}K{d}L{d}L{d}D{d}A{d}A{d}K{d}Q{d}I{d}L{d}{ct:Amid},D-MPI,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,15,Antimicrobial,0.4 % Hemolysis at 256 µM,Human,Polybia-Mpi Analogues,α-Helical,Non-hemolytic,CCHHHHHHHHTTTC,NA
7084,28453851,2017,rlwvlwrr,R{d}L{d}W{d}V{d}L{d}W{d}R{d}R{d},"D-Bac8c2,5Leu",Free,Free,Linear,D,None,8,Antimicrobial,50 % Hemolysis at 414 μg/ml,Human,Synthetic,NA,NA,CCCCCTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
7085,28453851,2017,fakllaklakkll,F{d}A{d}K{d}L{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}L{d},D-HB43,Free,Free,Linear,D,None,13,Antimicrobial,50 % Hemolysis at 77 μg/ml,Human,Synthetic,NA,NA,CHHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
7086,28453851,2017,flgglikivpamicavtkkc,F{d}L{d}G{d}G{d}L{d}I{d}K{d}I{d}V{d}P{d}A{d}M{d}I{d}C{d}A{d}V{d}T{d}K{d}K{d}C{d},D-Ranalexin,Free,Free,Linear,D,None,20,Antimicrobial,50 % Hemolysis at 195 μg/ml,Human,Synthetic,NA,NA,CCSCGGGTHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
7088,28453851,2017,wglrrllkygkrs,W{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d},"D-WMR3,6Leu",Free,Free,Linear,D,None,13,Antimicrobial,50 % Hemolysis at >4000 μg/ml,Human,Synthetic,NA,NA,CTHHHHHHHHCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
7089,28453851,2017,kwklfkklpkflhlakkf,K{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d},DP188Leu,Free,Free,Linear,D,None,13,Antimicrobial,50 % Hemolysis at 873 μg/ml,Human,Synthetic,NA,NA,CCSSTTHHHHHCCTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7090,28453851,2017,ilrwpwwpwrrk,I{d}L{d}R{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d}K{d},D-Omiganan,Free,Free,Linear,D,None,12,Antimicrobial,50 % Hemolysis at 1775.5 μg/ml,Human,Synthetic,NA,NA,CCCCCCCSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
7932,28981608,2017,ilgtilgllksl,I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid},D-CP,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,12,Antimicrobial,<0.2 % Hemolysis at <20 µM,Human,D-Counterpart Of Polybia-Cp,Left-hand α-Helical,NA,CCHHHHHHHHHC,NA
7935,28981608,2017,ilgtilgllksl,I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid},D-CP,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,12,Antimicrobial,<0.4 % Hemolysis at >30 µM,Human,D-Counterpart Of Polybia-Cp,Left-hand α-Helical,NA,CCHHHHHHHHHC,NA
7938,28981608,2017,ilgtilgllksl,I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid},D-CP,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,12,Antimicrobial,<0.5 % Hemolysis at <70 µM,Human,D-Counterpart Of Polybia-Cp,Left-hand α-Helical,NA,CCHHHHHHHHHC,NA
7941,28981608,2017,ilgtilgllksl,I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid},D-CP,Amidation,Free,Linear,D,lowercase letters correspond to D-amino acids,12,Antimicrobial,0.5 % Hemolysis at 130 µM,Human,D-Counterpart Of Polybia-Cp,Left-hand α-Helical,NA,CCHHHHHHHHHC,NA
8304,38062792,2023,kkllkllklll,K{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}L{d},EB11,Free,Free,Linear,D,None,11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
8882,28636788,2018,alksllktlskakaaklktllkalsk,A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D33,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Lys residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 89 µM,Human,Synthesized,α-Helical,NA,CCCHHHHTTCCCCTTCC,NA
8883,28636788,2018,alksllktlsaakkkklatllkalsk,A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}K{d}K{d}K{d}K{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D34,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Lys residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 126 µM,Human,Synthesized,α-Helical,NA,NA,NA
8884,28636788,2018,alksllatlskakkkklktllaalsk,A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D35,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Lys residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 30 µM,Human,Synthesized,α-Helical,NA,CCCCCCCCCGGGCCCCC,NA
8885,28636788,2018,alasllktlskakkkklktllkalsa,A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid},D36,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Lys residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 61 µM,Human,Synthesized,α-Helical,NA,CCCCCCCCCGGGCCCCC,NA
8886,28636788,2018,alksllktlskaaaaalktllkalsk,A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}A{d}A{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D37,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Ala residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 2.6 µM,Human,Synthesized,α-Helical,NA,CCCCCCCCCGGGCCCCC,NA
8887,28636788,2018,alksllktlsaaakkalatllkalsk,A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}A{d}K{d}K{d}A{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D38,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Ala residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 2.8 µM,Human,Synthesized,α-Helical,NA,CCCCCCCCCGGGCCCCC,NA
8888,28636788,2018,alksllatlskaakkalktllaalsk,A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D39,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Ala residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 2.8 µM,Human,Synthesized,α-Helical,NA,NA,NA
8889,28636788,2018,alasllktlskaakkalktllkalsa,A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid},D40,Amidation,Acetylation,Linear,D,Positions 13 and 16 are Ala residues is Non-polar{nnr},26,Antimicrobial peptides,30 % Hemolysis at 2.8 µM,Human,Synthesized,α-Helical,NA,NA,NA
9058,29515090,2018,kffkklknsvkkrakkffkkprvigvsipf,K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d},analog D-OH-CATH30,Free,Free,Linear,D,None,30,Antimicrobial,~10 % Hemolysis at 125 μg/ml,Human,Cathelicidin-Derived Peptide From The King Cobra,NA,NA,C,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
9060,29515090,2018,kffkklknsvkkrakkffkkprvigvsipf,K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d},analog D-OH-CATH30,Free,Free,Linear,D,None,30,Antimicrobial,80 % Hemolysis at 250 μg/ml,Human,Analog D-Oh-Cath30,NA,NA,CCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
9435,29760411,2018,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K{cyc},Paenialvin-C,Free,Free,Bicyclic,D,None,23,Antibacterial,0 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9713,30393205,2019,llwialrkk,L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},dCopW,Amidation,Free,Linear,D,None,9,Antibacterial,2.32 ± 0.78 % Hemolysis at 100 µM,Human,Synthetic Copw With D-Amino,NA,Non-hemolytic,CCCBTTTBSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9714,30393205,2019,llwialrkk(C6:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C6:0}{ct:Amid},dCopW1,Amidation,Free,Linear,D,C6 = hexanoic acid,9,Antibacterial,0.39 ± 0.66 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9715,30393205,2019,llwialrkk(C8:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C8:0}{ct:Amid},dCopW2,Amidation,Free,Linear,D,C8 = Octanoic Acid,9,Antibacterial,0.68 ± 0.47 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9716,30393205,2019,llwialrkk(C10:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C10:0}{ct:Amid},dCopW3,Amidation,Free,Linear,D,C10 = decanoic acid,9,Antibacterial,3.66 ± 0.39 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9717,30393205,2019,llwialrkk(C12:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C12:0}{ct:Amid},dCopW4,Amidation,Free,Linear,D,C12 = Dodecanoic Acid,9,Antibacterial,7.10 ± 0.32 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9718,30393205,2019,llwialrkk(C14:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C14:0}{ct:Amid},dCopW5,Amidation,Free,Linear,D,C14 = Tetradecanoic Acid,9,Antibacterial,8.36 ± 0.26 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9719,30393205,2019,llwialrkk(C16:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C16:0}{ct:Amid},dCopW6,Amidation,Free,Linear,D,C16 = hexadecanoic acid,9,Antibacterial,11.67 ± 0.55 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9720,30393205,2019,k(C10:0)krlaiwll,K{d}{conj:C10:0}K{d}R{d}L{d}A{d}I{d}W{d}L{d}L{d}{ct:Amid},Retro-dCopW3,Amidation,Free,Linear,D,C10 = decanoic acid,9,Antibacterial,20.88 ± 1.15 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9723,30488526,2019,kkffrawwaprflk,K{d}K{d}F{d}F{d}R{d}A{d}W{d}W{d}A{d}P{d}R{d}F{d}L{d}K{d}{ct:Amid},kk14,Amidation,Free,Linear,D,None,14,Antifungal,~10 % Hemolysis at 200 μg/ml,Sheep,Synthetic Analogues Of Kk14,"aqueous = Random coil, SDS = Random coil",Low hemolytic,CGGGSGGGGGTHHHHHHHHHHSCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9907,30848594,2019,klrsllrtlsrakaaklrtllralsr,K{d}L{d}R{d}S{d}L{d}L{d}R{d}T{d}L{d}S{d}R{d}A{d}K{d}A{d}A{d}K{d}L{d}R{d}T{d}L{d}L{d}R{d}A{d}L{d}S{d}R{d}{nt:Acet}{ct:Amid},D87(Lys'-6 Arg-1),Amidation,Acetylation,Linear,D,substituted with positive charged Arg,26,Antimicrobial,50 % Hemolysis at 12 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CTTTCCC,NA
9908,30848594,2019,klksllktlskakaaklktllkalsk,K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid},D84(Lys¹-6 Lys-1),Amidation,Acetylation,Linear,D,substituted with positive charged Lys,26,Antimicrobial,50 % Hemolysis at 155.5 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCCC,NA
9909,30848594,2019,klosllotlsoakaaklotlloalso,K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o},D85(Lys'-6 Orn-1),Amidation,Acetylation,Linear,D,o = D-Ornithine,26,Antimicrobial,50 % Hemolysis at 406.5 μg/ml,Human,Synthetic Peptide,α-Helix,NA,NA,NA
9912,30848594,2019,klksllktlskakaaklktllkalss,K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}S{d}{nt:Acet}{ct:Amid},D101(Lys' Ser26-5 Lys-1),Amidation,Acetylation,Linear,D,substituted with positive charged Lys,26,Antimicrobial,50 % Hemolysis at 279 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCC,NA
9914,30848594,2019,klosllotlsoaaaaalotlloalso,K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o},D85(K13A/K16A) -(Lys'-6 Orn-1),Amidation,Acetylation,Linear,D,o = D-Ornithine,26,Antimicrobial,50 % Hemolysis at 2.3 μg/ml,Human,Synthetic Peptide,α-Helix,NA,NA,NA
10111,31159194,2019,rrqrrkkrgygywgdimgewgneifgeiaeflgc,R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d}C{d},38d,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at 5 µM (pH 5.5),Human,Chimeric Peptide,NA,NA,CCTTHHHHTTSSCCCHHHHIIIIIITCSCGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
10112,31159194,2019,crrqrrkkrgygywgdimgewgneifgeiaeflg,C{d}R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d},38e,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at 0.1 µM (pH 5.5),Human,Chimeric Peptide,NA,NA,CCSSTTTGGGTSSSSCSSSCSSCTTCSSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
10113,31159194,2019,cglfeaiegfiengwegmidgwygygrkkrrqrr,C{d}G{d}L{d}F{d}E{d}A{d}I{d}E{d}G{d}F{d}I{d}E{d}N{d}G{d}W{d}E{d}G{d}M{d}I{d}D{d}G{d}W{d}Y{d}G{d}Y{d}G{d}R{d}K{d}K{d}R{d}R{d}Q{d}R{d}R{d},38f,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at 2.3 µM (pH 5.5),Human,Chimeric Peptide,NA,NA,CCSCSGGGGGGCCSTTSGGGCCCSSCCSCHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
10302,31159194,2019,rrqrrkkrgygywgdimgewgneifgeiaeflgc,R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d}C{d},38d,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at >100 µM (pH 7.4),Human,Chimeric Peptide,NA,NA,CCTTHHHHTTSSCCCHHHHIIIIIITCSCGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
10303,31159194,2019,crrqrrkkrgygywgdimgewgneifgeiaeflg,C{d}R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d},38e,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at 1.51 µM (pH 7.4),Human,Chimeric Peptide,NA,NA,CCSSTTTGGGTSSSSCSSSCSSCTTCSSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
10304,31159194,2019,cglfeaiegfiengwegmidgwygygrkkrrqrr,C{d}G{d}L{d}F{d}E{d}A{d}I{d}E{d}G{d}F{d}I{d}E{d}N{d}G{d}W{d}E{d}G{d}M{d}I{d}D{d}G{d}W{d}Y{d}G{d}Y{d}G{d}R{d}K{d}K{d}R{d}R{d}Q{d}R{d}R{d},38f,Free,Free,Linear,D,None,34,NA,50 % Hemolysis at >20 µM (pH 7.4),Human,Chimeric Peptide,NA,NA,CCSCSGGGGGGCCSTTSGGGCCCSSCCSCHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
10746,31847173,2019,kk(1-nal)fk(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,23 % Hemolysis at 150 µM,Human,Synthetic All D-Peptide Analogue Peptide,TFE = α-Helical,NA,NA,NA
10747,31847173,2019,ak(1-nal)fk(1-nal)k(nle),A{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-1,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,41 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10748,31847173,2019,ka(1-nal)fk(1-nal)k(nle),K{d}A{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-2,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,59 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10749,31847173,2019,kkafk(1-nal)k(nle),K{d}K{d}A{d}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-3,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,2 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,Low hemolytic,NA,NA
10750,31847173,2019,kk(1-nal)ak(1-nal)k(nle),K{d}K{d}{nnr:1-nal}A{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-4,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,22 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10751,31847173,2019,kk(1-nal)fa(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}A{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-5,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,47 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10752,31847173,2019,kk(1-nal)fkak(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}A{d}K{d}{nnr:nle}{ct:Amid},D2D analog-6,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,10 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10753,31847173,2019,kk(1-nal)fk(1-nal)a(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}A{d}{nnr:nle}{ct:Amid},D2D analog-7,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,67 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,NA,NA,NA
10754,31847173,2019,kk(1-nal)fk(1-nal)ka,K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}A{d}{ct:Amid},D2D analog-8,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,5 % Hemolysis at 150 µM,Human,D2D Analogues,α-Helical,Low hemolytic,NA,NA
10755,31847173,2019,kk(1-nal)f(1-nal)(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}{nnr:1-nal}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-9,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,20 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10756,31847173,2019,kk(1-nal)f(dap)(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}{nnr:dap}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-10,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid",8,Antimicrobial,28 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10757,31847173,2019,kk(1-nal)f(nle)(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}{nnr:nle}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-11,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,33 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10758,31847173,2019,kk(1-nal)ff(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}F{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-12,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,74 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10759,31847173,2019,kk(1-nal)fs(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}S{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-13,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,29 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10760,31847173,2019,kk(1-nal)ft(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}T{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-14,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,28 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10761,31847173,2019,kk(1-nal)fy(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}Y{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-15,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,40 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10762,31847173,2019,kk(1-nal)fv(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}V{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-16,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,54 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10763,31847173,2019,kk(1-nal)fk(1-nal)(1-nal)(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}{nnr:1-nal}{nnr:nle}{ct:Amid},D2D analog-17,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,89 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10764,31847173,2019,kk(1-nal)fk(1-nal)(dap)(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}{nnr:dap}{nnr:nle}{ct:Amid},D2D analog-18,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid",8,Antimicrobial,21 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10765,31847173,2019,kk(1-nal)fk(1-nal)(nle)(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}{nnr:nle}{nnr:nle}{ct:Amid},D2D analog-19,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,56 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10766,31847173,2019,kk(1-nal)fk(1-nal)f(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}F{d}{nnr:nle}{ct:Amid},D2D analog-20,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,91 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10767,31847173,2019,kk(1-nal)fk(1-nal)s(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}S{d}{nnr:nle}{ct:Amid},D2D analog-21,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,85 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10768,31847173,2019,kk(1-nal)fk(1-nal)t(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}T{d}{nnr:nle}{ct:Amid},D2D analog-22,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,66 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10769,31847173,2019,kk(1-nal)fk(1-nal)y(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}Y{d}{nnr:nle}{ct:Amid},D2D analog-23,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,74 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10770,31847173,2019,kk(1-nal)fk(1-nal)v(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}V{d}{nnr:nle}{ct:Amid},D2D analog-24,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,50 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10771,31847173,2019,kk(1-nal)fkk(1-nal)(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}K{d}{nnr:1-nal}{nnr:nle}{ct:Amid},D2D analog-25,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,50 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10772,31847173,2019,kk(1-nal)fk(1-nal)(nle)k,K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}{nnr:nle}K{d}{ct:Amid},D2D analog-26,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,18 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10773,31847173,2019,k(1-nal)fk(1-nal)k(nle),K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-27,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",7,Antimicrobial,49 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10774,31847173,2019,(1-nal)fk(1-nal)k(nle),{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-28,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",6,Antimicrobial,62 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10775,31847173,2019,fk(1-nal)k(nle),F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-29,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",5,Antimicrobial,12 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10776,31847173,2019,kk(1-nal)fk(1-nal)k,K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{ct:Amid},D2D analog-30,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, D-amino acid",7,Antimicrobial,11 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10777,31847173,2019,kk(1-nal)fk(1-nal),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}{ct:Amid},D2D analog-31,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, D-amino acid",6,Antimicrobial,20 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10778,31847173,2019,kk(1-nal)fk,K{d}K{d}{nnr:1-nal}F{d}K{d}{ct:Amid},D2D analog-32,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, D-amino acid",5,Antimicrobial,5 % Hemolysis at 150 µM,Human,D2D Analogues,NA,Low hemolytic,NA,NA
10779,31847173,2019,rk(1-nal)fk(1-nal)k(nle),R{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-33,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,60 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10780,31847173,2019,kr(1-nal)fk(1-nal)k(nle),K{d}R{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-34,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,35 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10781,31847173,2019,kk(1-nal)fr(1-nal)k(nle),K{d}K{d}{nnr:1-nal}F{d}R{d}{nnr:1-nal}K{d}{nnr:nle}{ct:Amid},D2D analog-35,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,49 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
10782,31847173,2019,kk(1-nal)fk(1-nal)r(nle),K{d}K{d}{nnr:1-nal}F{d}K{d}{nnr:1-nal}R{d}{nnr:nle}{ct:Amid},D2D analog-36,Amidation,Free,Linear,D,"1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid",8,Antimicrobial,51 % Hemolysis at 150 µM,Human,D2D Analogues,NA,NA,NA,NA
11004,32003561,2020,kwcfrvcyrglcyrrcrx,K{d}W{d}C{d}F{d}R{d}V{d}C{d}Y{d}R{d}G{d}L{d}C{d}Y{d}R{d}R{d}C{d}R{d}X{d},TPAD,Free,Free,Linear,D,None,18,Antibacterial,10 % Hemolysis at 16 μg/ml,Human,D-Amino Acid Analogue Of Tpi,β-Hairpin,NA,CCSSSCSSCBTTBCCCCCCCCCCCSSCCCCCCCSBCSSSBCCSSSCCCSCC,NA
11510,32590058,2020,gfgsllgkalrlganvl,G{d}F{d}G{d}S{d}L{d}L{d}G{d}K{d}A{d}L{d}R{d}L{d}G{d}A{d}N{d}V{d}L{d}{ct:Amid},DCPF-C1,Amidation,Free,Linear,D,None,17,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical (reverse Helical),NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11515,32590058,2020,GFGSLLGKALRLWKKVL,GFGSLLGKALRLWKKVL{ct:Amid},CPF-13,Amidation,Free,Linear,D,None,17,Antibacterial,≥75 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical,NA,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11540,32786271,2020,kﬀkrllksvrravkkfrk,K{d}F{d}F{d}K{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid},HC1-D2,Amidation,Free,Linear,D,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",31 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = α-Helix",NA,CTHHHHHHHHHHHHHHHTTSCCCSSCCSCC,NA
11544,32786271,2020,kﬀkrllksvrravkkfrk,K{d}F{d}F{d}K{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid},HC1-D2,Amidation,Free,Linear,D,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",12 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = α-Helix",NA,CCSSHHHHHHHHHCSSCC,NA
11734,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,10 % Hemolysis at 1200 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCCSSTTCSCSTTCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11735,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,0 % Hemolysis at 500 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11736,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,0 % Hemolysis at 600 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11758,33532575,2021,kykkalkklakll,K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d},D-SB1,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCTTSCCCCGGGHHHHHHHHHHHHHHHHTTTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
11760,33532575,2021,vqwrairvrvir,V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d},D-DJK5,Free,Free,Linear,D,None,12,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
11762,33532575,2021,ilpwkwpwwpwrr,I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d},D-Indo,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11764,33532575,2021,klklklklklklklklkklkklkklkklkklkklkkl,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d},D-G3KL,Free,Free,Branched,D,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCSTTTSCSSCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11766,33532575,2021,ofofofofkblkblkklk(C10),O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10},D-TNS18,Free,Free,Branched,D,None,18,Antibacterial. Antibiofilm,MHC at 500 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Low hemolytic,CCSTTTSTTCCCSSCCCCCCCCC,NA
11768,33532575,2021,klklklklklklklklkklkklkklkklkllkllkkll,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d},D-T25,Free,Free,Branched,D,None,38,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,NA,NA,CCCTTHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11928,33890759,2021,kriwqrik,K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}{nt:C10}{ct:Amid},C10-KR8d,Amidation,C10,Linear,D,nter = C10,8,Antibacterial,50 % Hemolysis at 300 µM,Human,Synthetic Peptide,NA,Low hemolytic,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11933,33890759,2021,kriwqrikdf,K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}D{d}F{d}{nt:C8}{ct:Amid},C8-KR10d,Amidation,C8,Linear,D,nter = C8,10,Antibacterial,50 % Hemolysis at 150 µM,Human,Synthetic Peptide,NA,NA,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12015,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 33.26 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12016,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 1 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12017,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 2 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12018,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.4 % Hemolysis at 4 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12019,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.5 % Hemolysis at 8 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12020,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.9 % Hemolysis at 16 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12021,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",2.5 % Hemolysis at 32 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12022,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",8.7 % Hemolysis at 64 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12023,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",23.6 % Hemolysis at 128 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12024,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",65.6 % Hemolysis at 256 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12231,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",35.1 ± 8.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12262,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",64.4 ± 9.4 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12293,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",71.0 ± 7.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12451,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,1.94 ± 0.94 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12465,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,2.75 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12479,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,30.39 ± 2.11 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12493,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,51.40 ± 1.94 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12654,36551443,2022,grrrrsvqwca,G{d}R{d}R{d}R{d}R{d}S{d}V{d}Q{d}W{d}C{d}A{d},hLF 1-11(D-form),Free,Free,Linear,D,None,11,Antimycobacterial,<1 % Hemolysis at 4000 μg/ml,Human,Homo Sapiens,NA,Non-hemolytic,CCTTGGGTTTTCC,CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
12866,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid},D-W3R6,Amidation,Free,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of W3R6,NA,Low hemolytic,CCHHHHTTTTC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12868,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid},D-Arg-W3R6,Amidation,Free,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Diastereomer Of W3R6,NA,Low hemolytic,CCHHHHTTTTC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12869,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:Acetylation(CH3COOH)}{ct:Amid},AC-D-W3R6,Amidation,Acetylation(CH3COOH),Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of D-W3R6 (Acetyl),NA,Low hemolytic,CCCGGGGGGTTC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12870,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:butanoyl = CH3(CH2)2COOH}{ct:Amid},BA-D-W3R6,Amidation,butanoyl = CH3(CH2)2COOH,Linear,D,nter = butanoyl,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of D-W3R6 (Butanoyl),NA,Low hemolytic,CCSSCEETTEECC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12871,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:octanoyl = C8H16O2}{ct:Amid},OA-D-W3R6,Amidation,octanoyl = C8H16O2,Linear,D,nter = octanoyl,11,Antimycobacterial,50 % Hemolysis at 100 µM,Human,Lipidated Analog Of D-W3R6 (Octanoyl),NA,NA,CCSSCGGGSSSCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12872,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:lauric acyl = C12H24O2}{ct:Amid},LA-D-W3R6,Amidation,lauric acyl = C12H24O2,Linear,D,nter = lauric acyl,11,Antimycobacterial,50 % Hemolysis at 25 µM,Human,Lipidated Analog Of D-W3R6 (Lauric Acid),NA,NA,CCCHHHHHHTTCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12873,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:palmitic acyl = C16H32O2}{ct:Amid},PA-D-W3R6,Amidation,palmitic acyl = C16H32O2,Linear,D,nter = palmitic acyl,11,Antimycobacterial,50 % Hemolysis at 25 µM,Human,Lipidated Analog Of D-W3R6 (Palmitic Acid),NA,NA,CCCCCTTTSTTTC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13448,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid},BP214,Amidation,Free,Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,41 % Hemolysis at 150 µM,Human,Synthetic,NA,NA,CTTHHHHHHHC,NA
13449,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C4)}{ct:Amid},1,Amidation,lipidated (C4),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp214,NA,NA,CTTHHHHHHHC,NA
13450,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C6)}{ct:Amid},2,Amidation,lipidated (C6),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp215,NA,NA,CTTHHHHTTCC,NA
13451,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C8)}{ct:Amid},3,Amidation,lipidated (C8),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp216,NA,NA,CTTHHHHTTCC,NA
13452,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C10)}{ct:Amid},4,Amidation,lipidated (C10),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp217,NA,NA,CTTHHHHTTCC,NA
13453,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C12)}{ct:Amid},5,Amidation,lipidated (C12),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp218,NA,NA,CTTHHHHTTCC,NA
13454,36009951,2022,kklfkkilryl,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C14)}{ct:Amid},6,Amidation,lipidated (C14),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp219,NA,NA,CTTHHHHTTCC,NA
13455,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid},7,Amidation,Free,Linear,D,Lower-case letters signify D-amino acids,11,Antimicrobial,3 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp220,NA,NA,CTTHHHHTTCC,NA
13456,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid},8,Amidation,Free,Linear,D,Lower-case letters signify D-amino acids,11,Antimicrobial,3 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp221,NA,NA,CTTHHHHTTCC,NA
13457,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid},9,Amidation,Free,Linear,D,Lower-case letters signify D-amino acids,11,Antimicrobial,3 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp222,NA,NA,CTTHHHHTTCC,NA
13458,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid},10,Amidation,lipidated (C10),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,81 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp223,NA,NA,CTTHHHHTTCC,NA
13459,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid},11,Amidation,lipidated (C12),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,96 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp224,NA,NA,CTTHHHHTTCC,NA
13460,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid},12,Amidation,lipidated (C14),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,95 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp225,NA,NA,CTTHHHHTTCC,NA
13461,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid},13,Amidation,lipidated (C10),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,36 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp226,NA,NA,CTTHHHHTTCC,NA
13462,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid},14,Amidation,lipidated (C12),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,98 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp227,NA,NA,CCCCGGGTTTTTTTC,NA
13463,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid},15,Amidation,lipidated (C14),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,83 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp228,NA,NA,CCCCGGGTCTTTSCC,NA
13464,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid},16,Amidation,lipidated (C10),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,59 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp229,NA,NA,CCCCTHHHHHHHTCC,NA
13465,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid},17,Amidation,lipidated (C12),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp230,NA,NA,CCTTHHHHHHHTTCC,NA
13466,36009951,2022,kklfkkilryk,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid},18,Amidation,lipidated (C14),Linear,D,C= lipidated; Lower-case letters signify D-amino acids,11,Antimicrobial,94 % Hemolysis at 150 µM,Human,Synthetic; C-Locked Analog Of Bp231,NA,NA,CCCCGGGTTTGGGCC,NA
13681,35812346,2022,rrrrrrrrrrrrrrrrrr,R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}{nt:H}{ct:OH},R18D (acetate),OH,H,Linear,D,Lower case r = d-arginine,18,Mast cell degranulation inducer,No Hemolysis at 16 µM,Human,Synthetic,NA,Non-hemolytic,CTTTTTTTSSSCC,NA
13748,36297519,2022,kkirvrlsa,K{d}K{d}I{d}R{d}V{d}R{d}L{d}S{d}A{d},M33D,Free,Free,Linear,D,None,9,Antimicrobial,NA,Human,Synthetic,NA,Non-hemolytic,CCTTHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
13749,36297519,2022,kklrvrlsa,K{d}K{d}L{d}R{d}V{d}R{d}L{d}S{d}A{d},M33i/l,Free,Free,Linear,D,None,9,Antimicrobial,NA,Human,Synthetic,NA,Non-hemolytic,CCTTHHHHHHHTTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
13821,10931184,2000,gildtiksiaskvwnsktvqdlkrkginwvanklgvspqaa,G{d}I{d}L{d}D{d}T{d}I{d}K{d}S{d}I{d}A{d}S{d}K{d}V{d}W{d}N{d}S{d}K{d}T{d}V{d}Q{d}D{d}L{d}K{d}R{d}K{d}G{d}I{d}N{d}W{d}V{d}A{d}N{d}K{d}L{d}G{d}V{d}S{d}P{d}Q{d}A{d}A{d},D-isomer Hadrurin,Free,Free,Linear,D,None,41,"Antibacterial, hemolytic",100 % Hemolysis at 5 µM,Human,"Venom, Hadrurus Aztecus, Mexico, North America",NA,NA,CCGGGHHHHHHHHHCSSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
14256,31209048,2019,glslllslglkll,G{d}L{d}S{d}L{d}L{d}L{d}S{d}L{d}G{d}L{d}K{d}L{d}L{d}{ct:Amid},DFT503d,Amidation,Free,Linear,D,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O